Predictive value of urinary low molecular weight proteins for progression of early diabetic nephropathy in patient with type 2 diabetes mellitus
Xiang Hong-din
Abstract
Xiang Hong-din
Abstract
Objective To investigate the predictive value of urinary low molecular weight proteins for progression of diabetic nephropathy in type 2 diabetic patient with microalbuminuria. Methods Urinary excretion amounts of alpha-1-microglobulin (α1-MG), retinal-binding protein (RBP), N-acetyl-beta-D-glucosaminidase (NAG) and beta-2-microglobulin (β2-MG) were determined in 66 patients of type 2 diabetes mellitus with microalbuminuria at baseline. The patients were followed up for 3 1~5 5 years 〔(4 18±0 61) years〕 and then divided into two groups(progression group and non-progression group) according to whether or not to progress to clinical diabetic nephropathy during the follow-up period. Results 18 of 66 patients progressed to clinical diabetic nephropathy during follow-up period. The initial urinary α1-MG,RBP,NAG excretion level in progression group were higher significantly than that in non-progression group respectively(α1-MG:4 33±2 15 vs 1 50±0 27 mg/L;RBP:63 6±36 6 vs.18 8±19 6 ng/mmol; NAG: 14 2±1 44 vs 2 45±2 09 U/mmol, P respectively 0 01). But the initial urinary β2-MG level was not significantly different between the two groups. There were 83 3%,89 9% and 44 4% of patients in progression group who showed an abnormal elevation of initial urinary α1-MG,RBP,NAG excretion levels, respectively, while compared with the reference range of normal healthy adults, which were higher significantly than in non-progression group(P0 01). But the percentage of patients with abnormal initial urinary β2-MG excretion level was not significantly different between the two groups(P0 05). The mean HbA1c, blood lipid levels, blood pressure during follow-up period were not significantly different between the two groups. Conclusions Measurements of urinary α1-MG,RBP and NAG may be useful for predicting whether or not development of clinical diabetic nephropathy in patient of type 2 diabetes mellitus with microalbuminuria. Elevation of urinary α1-MG,RBP and NAG level may be one of characteristics of early diabetic nephropathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the predictive value of urinary low molecular weight proteins for progression of diabetic nephropathy in type 2 diabetic patient with microalbuminuria. Methods Urinary excretion amounts of alpha-1-microglobulin (α1-MG), retinal-binding protein (RBP), N-acetyl-beta-D-glucosaminidase (NAG) and beta-2-microglobulin (β2-MG) were determined in 66 patients of type 2 diabetes mellitus with microalbuminuria at baseline. The patients were followed up for 3 1~5 5 years 〔(4 18±0 61) years〕 and then divided into two groups(progression group and non-progression group) according to whether or not to progress to clinical diabetic nephropathy during the follow-up period. Results 18 of 66 patients progressed to clinical diabetic nephropathy during follow-up period. The initial urinary α1-MG,RBP,NAG excretion level in progression group were higher significantly than that in non-progression group respectively(α1-MG:4 33±2 15 vs 1 50±0 27 mg/L;RBP:63 6±36 6 vs.18 8±19 6 ng/mmol; NAG: 14 2±1 44 vs 2 45±2 09 U/mmol, P respectively 0 01). But the initial urinary β2-MG level was not significantly different between the two groups. There were 83 3%,89 9% and 44 4% of patients in progression group who showed an abnormal elevation of initial urinary α1-MG,RBP,NAG excretion levels, respectively, while compared with the reference range of normal healthy adults, which were higher significantly than in non-progression group(P0 01). But the percentage of patients with abnormal initial urinary β2-MG excretion level was not significantly different between the two groups(P0 05). The mean HbA1c, blood lipid levels, blood pressure during follow-up period were not significantly different between the two groups. Conclusions Measurements of urinary α1-MG,RBP and NAG may be useful for predicting whether or not development of clinical diabetic nephropathy in patient of type 2 diabetes mellitus with microalbuminuria. Elevation of urinary α1-MG,RBP and NAG level may be one of characteristics of early diabetic nephropathy.
Key concepts: Microalbuminuria, Diabetic nephropathy, Medicine, Internal medicine, Beta-2 microglobulin, Urinary system, Diabetes mellitus, Nephropathy